IVERIC bio Inc
US ˙ NASDAQ ˙ US46583P1021
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityISEE / IVERIC bio Inc
InstitutionJefferies Group LLC
Latest Disclosed Ownership19,510 shares
Latest Disclosed Value $ 350,009
Jefferies Group LLC ownership in ISEE / IVERIC bio Inc

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 19,510 shares of IVERIC bio Inc (US:ISEE) valued at $350,009 USD as of September 30, 2022. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 659 shares of IVERIC bio Inc. This represents a change in shares of 2,860.55% during the quarter. The current value of the position is $779,424 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (ISEE) in the form of stock options. The firm currently holds call options representing 40,000 of underlying shares valued at $717,600 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ISEE / IVERIC bio Inc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 IVERIC BIO COM 46583P102 19,510 18,851 2,860.55 350 5,733.33 0.0029
2022-11-14 2022-09-30 13F IVERIC BIO COM 46583P102 19,510 18,851 350 0.0028
2023-09-21 2022-06-30 13F/A-1 IVERIC BIO COM 46583P102 659 -2,012 -75.33 6 -86.36 0.0001
2022-08-15 2022-06-30 13F IVERIC BIO COM 46583P102 659 -2,012 6 0.0000
2023-09-21 2022-03-31 13F/A-1 IVERIC BIO COM 46583P102 2,671 2,671 45 0.0003
2022-05-16 2022-03-31 13F IVERIC BIO COM 46583P102 2,671 2,671 45 0.0003
2023-09-21 2021-12-31 13F/A-1 IVERIC BIO COM 46583P102 0 -58,115 -100.00 0 -100.00
2022-02-12 2021-12-31 13F IVERIC BIO COM 46583P102 0 -58,115 0
2023-09-21 2021-09-30 13F/A-2 IVERIC BIO COM 46583P102 58,115 -191,885 -76.75 944 -40.20 0.0069
2021-12-17 2021-09-30 13F/A-1 IVERIC BIO COM 46583P102 58,115 -191,885 944 0.0065
2021-11-15 2021-09-30 13F IVERIC BIO COM 46583P102 58,115 -191,885 944 0.0061
2023-09-21 2021-06-30 13F/A-2 IVERIC BIO COM 46583P102 250,000 250,000 1,578 0.0099
2021-08-20 2021-06-30 13F/A-1 IVERIC BIO COM 46583P102 250,000 250,000 1,578 0.0093
2021-08-16 2021-06-30 13F IVERIC BIO COM 46583P102 250,000 250,000 1,578 0.0093
2017-02-14 2016-12-31 13F/A-1 OPHTHOTECH COM 683745103 0 -22,170 -100.00 0 -100.00
2016-11-14 2016-09-30 13F OPHTHOTECH COM 683745103 22,170 -8,104 -26.77 1,023 -33.79 0.0053
2016-08-12 2016-06-30 13F OPHTHOTECH COM 683745103 30,274 30,274 36.55 1,545 51.03 0.0070
2016-05-11 2016-03-31 13F OPHTHOTECH COM 683745103 0 0 0 0.0000
2016-02-12 2015-12-31 13F OPHTHOTECH COM 683745103 0 0 0 0.0000
2015-11-13 2015-09-30 13F OPHTHOTECH COM 683745103 0 -73 -100.00 0 -100.00
2015-08-18 2015-06-30 13F OPHTHOTECH COM 683745103 73 73 4 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A IVERIC BIO COM Call 40,000 1,042.86 718 2,072.73 n/a n/a n/a
2022-11-14 2022-09-30 13F IVERIC BIO COM Call 40,000 718 n/a n/a n/a
2023-09-21 2022-06-30 13F/A IVERIC BIO COM Call 3,500 -91.76 34 -95.38 n/a n/a n/a
2022-08-15 2022-06-30 13F IVERIC BIO COM Call 3,500 34 n/a n/a n/a
2023-09-21 2022-03-31 13F/A IVERIC BIO COM Call 42,500 715 n/a n/a n/a
2022-05-16 2022-03-31 13F IVERIC BIO COM Call 42,500 715 n/a n/a n/a
2017-05-15 2017-03-31 13F OPHTHOTECH COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F/A OPHTHOTECH COM Call 17,700 -74.61 85 -97.36 n/a n/a n/a
2017-02-14 2016-12-31 13F OPHTHOTECH COM Call 17,700 85 n/a n/a n/a
2016-11-14 2016-09-30 13F OPHTHOTECH COM Call 69,700 125.57 3,215 103.87 n/a n/a n/a
2016-08-12 2016-06-30 13F OPHTHOTECH COM Call 30,900 1,577 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A IVERIC BIO COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F IVERIC BIO COM Put 0 0 n/a n/a n/a
2023-09-21 2022-06-30 13F/A IVERIC BIO COM Put 16,800 162 n/a n/a n/a
2022-08-15 2022-06-30 13F IVERIC BIO COM Put 16,800 162 n/a n/a n/a
2023-09-21 2021-12-31 13F/A IVERIC BIO COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-12 2021-12-31 13F IVERIC BIO COM Put 0 0 n/a n/a n/a
2021-12-17 2021-09-30 13F/A IVERIC BIO COM Put 8,000 130 n/a n/a n/a
2023-09-21 2021-09-30 13F/A IVERIC BIO COM Put 8,000 130 n/a n/a n/a
2021-11-15 2021-09-30 13F IVERIC BIO COM Put 8,000 130 n/a n/a n/a
2017-05-15 2017-03-31 13F OPHTHOTECH COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F/A OPHTHOTECH COM Put 200 -98.52 1 -99.84 n/a n/a n/a
2017-02-14 2016-12-31 13F OPHTHOTECH COM Put 200 1 n/a n/a n/a
2016-11-14 2016-09-30 13F OPHTHOTECH COM Put 13,500 623 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.